Suppr超能文献

胰岛淀粉样多肽通过靶向CCN1并影响PI3K/AKT信号通路来抑制胃癌进展。

Amylin inhibits gastric cancer progression by targeting CCN1 and affecting the PI3K/AKT signalling pathway.

作者信息

Liu Li, Liu Wenxuan, Deng Wenhong

机构信息

Department of General Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, China.

出版信息

Ann Med. 2025 Dec;57(1):2480754. doi: 10.1080/07853890.2025.2480754. Epub 2025 Mar 31.

Abstract

METHODS

This study used a combination of and experiments to investigate the role of amylin in the progression of GC. The expression of amylin in GC and its clinical correlation were evaluated using 38 pairs of GC and healthy human clinical samples. studies, human GC cell lines were treated with amylin to evaluate the effects of amylin on the proliferation, apoptosis and migration of GC cells. In studies, xenograft mouse models were established by subcutaneous injection of GC cells into nude mice, followed by treatment with amylin to assess tumor growth. Finally, Next-Generation Sequencing Technology (RNA-seq) was used to explore the potential mechanism of amylin on GC.

RESULTS

We found that amylin expression was reduced in GC compared to adjacent normal gastric tissues and that elevated amylin expression was negatively correlated with adverse pathological factors ( < 0.05). Additionally, we demonstrated that amylin impeded the growth, invasion, migration, and colony formation of GC cells and suppressed the epithelial-to-mesenchymal transformation of these cells ( < 0.05). Tumour xenograft model experiments confirmed the tumour-suppressive effect of amylin in subcutaneous tumours in nude mice ( < 0.05). Transcriptome sequencing (RNA-seq) revealed that amylin significantly down-regulated CCN1 gene expression in GC cells ( < 0.001). Further intervention targeting CCN1 verified its significance as a target of amylin's anti-carcinogenic function in GC. Additionally, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis revealed that amylin exerted its oncogenic effects by inhibiting the PI3K/Akt signalling pathway ( < 0.05).

CONCLUSIONS

Our findings demonstrate that amylin plays a crucial role in suppressing gastric cancer progression by targeting CCN1 and inhibiting the PI3K/Akt signalling pathway. These results suggest that amylin could serve as a potential therapeutic agent for GC treatment.

摘要

方法

本研究采用[具体实验方法1]和[具体实验方法2]实验相结合的方式,探讨胰岛淀粉样多肽在胃癌进展中的作用。使用38对胃癌及健康人临床样本评估胰岛淀粉样多肽在胃癌中的表达及其临床相关性。在[细胞实验相关]研究中,用胰岛淀粉样多肽处理人胃癌细胞系,以评估其对胃癌细胞增殖、凋亡和迁移的影响。在[动物实验相关]研究中,通过将胃癌细胞皮下注射到裸鼠体内建立异种移植小鼠模型,随后用胰岛淀粉样多肽进行处理以评估肿瘤生长情况。最后,采用新一代测序技术(RNA测序)探索胰岛淀粉样多肽对胃癌作用的潜在机制。

结果

我们发现,与相邻正常胃组织相比,胃癌中胰岛淀粉样多肽表达降低,且胰岛淀粉样多肽表达升高与不良病理因素呈负相关(P<0.05)。此外,我们证明胰岛淀粉样多肽可抑制胃癌细胞的生长、侵袭、迁移和集落形成,并抑制这些细胞的上皮-间质转化(P<0.05)。肿瘤异种移植模型实验证实了胰岛淀粉样多肽对裸鼠皮下肿瘤的抑制作用(P<0.05)。转录组测序(RNA测序)显示,胰岛淀粉样多肽显著下调胃癌细胞中CCN1基因的表达(P<0.001)。进一步针对CCN1的干预证实了其作为胰岛淀粉样多肽在胃癌中抗癌功能靶点的重要性。此外,京都基因与基因组百科全书(KEGG)通路富集分析显示,胰岛淀粉样多肽通过抑制PI3K/Akt信号通路发挥其致癌作用(P<0.05)。

结论

我们的研究结果表明,胰岛淀粉样多肽通过靶向CCN1并抑制PI3K/Akt信号通路在抑制胃癌进展中起关键作用。这些结果表明,胰岛淀粉样多肽可作为胃癌治疗的潜在治疗药物。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验